Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer

doi:10.5306/wjco.v5.i5.1048

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7111)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

518

WORD

212

HTML

3742

Figures (1-4)

158

Sum=4630

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1282

Download

1199

Sum=2481

Dec 10, 2014 (publication date) through Oct 3, 2024

Times Cited of This Article

Times Cited (52)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Dec 10, 2014; 5(5): 1048-1054
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.1048

Full Size Figure Download Figure

Figure 4 Chemotherapeutic algorithm. PEM: Pemetrexed; GEM: Gemcitabine; CDDP: Cisplatin; CBDCA: Carboplatin; DOC: Docetaxel; EGFR-TKI: Epidermal growth factor receptor tyrosine kinase inhibitor; ALK: Anaplastic lymphoma kinase fusion gene.

Citation: Yano T, Okamoto T, Fukuyama S, Maehara Y. Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer. World J Clin Oncol 2014; 5(5): 1048-1054
URL: https://www.wjgnet.com/2218-4333/full/v5/i5/1048.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i5.1048